Compared with vehicle-treated ALI model group, DYY-4 at 30 and 60 mg/kg markedly lowered the levels of TNF-α, IL-6, and IL-1β (p < 0.01) depicted in Figure 4 respectively. This evidence concerns the gene TNF and acute respiratory distress syndrome.